upda te in pa llia tive ca re
play

Upda te in Pa llia tive Ca re L I SA ANSE L MO PHARM.D BCOP - PDF document

9/29/2016 Upda te in Pa llia tive Ca re L I SA ANSE L MO PHARM.D BCOP UNI VE RSI T Y OF NE W ME XI CO CANCE R CE NT E R Ca se 64 yo fe ma le with me ta sta tic o va ria n c a nc e r T re a te d with pa c lita xe l c


  1. 9/29/2016 Upda te in Pa llia tive Ca re L I SA ANSE L MO PHARM.D BCOP UNI VE RSI T Y OF NE W ME XI CO CANCE R CE NT E R Ca se  64 yo fe ma le with me ta sta tic o va ria n c a nc e r  T re a te d with pa c lita xe l c a rb o pla tin  Se ve ra l surg e rie s  Ma in c o mpla int ne uro pa thy in fe e t a nd le g s  Anxio us a b o ut dise a se a nd pro g re ssio n  Ma na g ing pa in with me dic a l ma rijua na 1

  2. 9/29/2016 Pa llia tive c a re re c s  Oxyc o do ne fo r pa in  Bo we l re g ime n  Co unse ling fo r a nxie ty Pa llia tive c a re  Appro xima te ly 2.6 millio n pe o ple die in the US  Usua lly a s a re sult o f a c hro nic illne ss (c a nc e r a nd he a rt dise a se )  Pa llia tive c a re  Sympto m ma na g e me nt  Pa tie nts g o a ls  Ca re g ive r suppo rt  Whe n pro vide d to pa tie nts with so me type s o f c a nc e r it c a n a c tua lly pro lo ng life Pa tie nt a nd fa mily-c e nte re d c a re tha t o ptimize s q ua lity o f life b y a ntic ipa ting , pre ve nting , a nd tre a ting suffe ring 2

  3. 9/29/2016 De finitio ns  Wo rld He a lth Org a niza tio n Pa llia tive c a re  I mpro ve s the q ua lity o f life o f the pa tie nt thro ug h sympto m c o ntro l  I mpro ve s QOL fo r fa mily  Also a ddre sse s spiritua l a nd psyc o so c ia l a spe c ts o f pa tie nt c a re  Do e s no t ha ste n o r impe de de a th  T e a m a ppro a c h  Physic ia ns, nurse s, so c ia l wo rke rs, pha rma c ists, c ha pla in, music the ra pist  Ca n b e utilize d a t a ny time during the c o urse o f a c hro nic illne ss De finitio n  Ho spic e  A ho me pro viding c a re fo r the te rmina lly ill  Ho spic e c a re is tre a ting sympto ms a t the e nd o f life so the pa tie nt c a n die with dig nity.  Also pro vid e e mo tio na l a nd spiritua l suppo rt fo r the pa tie nt a nd fa mily.  T re a tme nts fo r the te rmina l illne ss a re sto ppe d whe n ho spic e c a re is initia te d.  T o b e e lig ib le fo r the ho spic e b e ne fit tre a tme nt must fo c us o n sympto m c o ntro l no t dise a se tre a tme nt.  http:/ / www.nhpc o .o rg / a b o ut/ ho spic e -c a re 3

  4. 9/29/2016 Ro le o f the Pha rma c ist  Pa rtic ipa te in te a m me e ting s  Re vie w me dic a tio ns fo r drug inte ra c tio ns  Re vie w me dic a tio ns fo r dise a se sta te inte ra c tio ns  Re c o mme nda tio ns fo r sympto m ma na g e me nt  E duc a te pa tie nts a nd fa milie s Sympto m ma na g e me nt  Pa in  Na use a / vo miting  Co nstipa tio n  Dyspne a  L ive r dise a se 4

  5. 9/29/2016 Pa in ma na g e me nt  Asse ssme nt  Sc a le , 1-10.  Wha t is the pa tie nt’ s g o a l? Wha t c a n the y live with?  L o c a tio n, q ua lity, o nse t, type o f pa in  No c ic e ptive vs ne uro pa thic pa in  No c ic e ptive is so ma tic o r visc e ra l pa in  So ma tic pa in re sults fro m b o ne , jo int, musc le o r c o nne c tive tissue  L o c a tlize d, a c hing thro b b ing pa in  Re spo nsive to NSAI Ds o r ste ro ids o r ra dia tio n Visc e ra l pa in  Orig ina te s in inte rna l o rg a ns  Cra mping , a c hing , pre ssure  Ca use d b y b o we l o b struc tio n o r c a nc e r me ta sta sis to live r  Opio ids , a ntie me tic s o r a ntic ho line rg ic s mig ht he lp 5

  6. 9/29/2016 Ne uro pa thic pa in  Ca use d b y dysfunc tio n in the CNS  Numb ne ss, ting ling , b urning , o r ra dia ting pa in  Opio ids ma y wo rk, o fte n ne e d a me dic a tio n with a diffe re nt me c ha nism o f a c tio n  T CAs, musc le re la xa nts, a nti e pile ptic s WHO pa in ma na g e me nt la dde r  Ste p wise a ppro a c h  Ac e ta mino phe n…. No ne e d to disc uss  NSAI Ds-  COX 2s  Opio ids  http:/ / pa indr.c o m/ ho me /  Anti e pile ptic s  Ga b a pe ntin a nd pre g a b a lin  ste ro ids 6

  7. 9/29/2016 7

  8. 9/29/2016 Ne uro pa thic pa in  Me ta a na lysis pub lishe d in F e b 2015  I nc lude d tria ls tha t la ste d a t le a st 3 we e ks  F irst line re c o mme nda tio ns:  g a b a pe ntin o r e xte nde d re le a se g a b a pe ntin o r e na c a rb il 1200mg to 3600mg / da y  Pre g a b a lin 300 mg to 600 mg / da y  Dulo xe tine 60 mg to 120 mg / da y  Ve nla fa xine E R 150-225 mg / da y  T ric yc lic a ntide pre ssa nts (o ne no t re c o mme nde d o ve r o the rs) Ne uro pa thic pa in  Se c o nd line use - we a k e vide nc e  Ca psa ic in 8% pa tc he s- o ne to 4 pa tc he s a pplie d fo r up to 60 mins e ve ry 3 mo nths  L ido c a ine pa tc he s o ne to 3 pa tc he s o nc e a da y fo r up to 12 ho urs  T ra ma do l 200-400 mg / da y  T a pe nta do l 8

  9. 9/29/2016 Ne uro pa thic pa in  T hird line  Bo tulinum to xin A sub Q 50-200 units e ve ry 3 mo nths  Opio ids  Me tha do ne fo r ne uro pa thic pa in  Blo c ks the NMDA re c e pto rs  T itra te slo wly  Opio id a dve rse e ffe c ts  QT c pro lo ng a tio n a t hig he r do se s ha s b e e n se e n a t 200 mg do se s  Ge t b a se line E K G Ne uro pa thic pa in  Co mb ina tio n re g ime ns  Pe g a b a lin o r g a b a pe ntin a nd dulo xe tine o r T CAs  Go o d re g ime n to c o mb ine inste a d o f trying to push the do se s o f the individua l me dic a tio ns 9

  10. 9/29/2016 Opio ids  F DA o pio id a c tio n pla n  Ab use de te rre nt fo rmula tio ns  Wa rning s a nd sa fe ty info rma tio n o n sho rt a c ting fo rmula tio ns  I nc re a se pro vide r tra ining  Re vie wing the pa in ma na g e me nt re c o mme nda tio ns Ab use de te rre nt fo rmula tio ns  Physic a l c he mic a l b a rrie rs  Use ta b le t fo rmula tio n to pre ve nt e xtra c ting the o pio id thro ug h so lve nts  Ag o nist/ Anta g o nist c o mb ina tio ns  Anta g o nist c a n b e se q ue ste re d a nd re le a se d upo n ma niupula tio n 10

  11. 9/29/2016 Mo rphine / na ltre xo ne (E mb e da )  No ve l a g e nt- c o nta ins pe lle ts o f mo rphine a nd se q ue ste re d na ltre xo ne Mo rphine / na ltre xo ne (E mb e da )  I nitia l do se s sta rt a t 20mg / 0.8mg o nc e a da y  T itra te e ve ry 1 to 2 da ys  Co nve rsio n fro m o ra l mo rphine  Give ha lf o f the to ta l da ily mo rphine do se a s E mb e da q 12 ho urs OR a ll o f the pa tie nt’ s to ta l da ily do se a s E mb e da o nc e a da y  Co nve rsio n fro m o the r o pio ids to E mb e da  Dc a ll o pio ids, initia te E mb e da a t 30mg / 1.2mg o nc e a da y No e sta b lishe d c o nve rsio n ra tio s to E mb e da  Ora l do se 3x the I V 11

  12. 9/29/2016 Othe r a b use de te rre nt fo rmula tio ns  Zo hydro E R (hydro c o do ne )  Opa na E R (o xymo rpho ne )  E xa lg o E R 24hr (hydro mo rpho ne ) Dyspne a  No stric t de finitio ns  Pa tie nt pe rc e ptio n o f a wa re ne ss o f b re a thing a nd unc o mfo rta b le ne ss  Ca use s pa nic wo rry, c o nfusio n, frustra tio n a nd a ng e r  T re a t the unde rlying c a use if po ssib le  COPD, CHF , pne umo nia , PE , lympho ma  Re po sitio n the pa tie nt mo re upwa rd po sitio n  Oxyg e n ma y no t b e e ffe c tive , pa tie nts who re po rt b re a thle ssne ss ma y no t b e hypo xe mic 12

  13. 9/29/2016 Dyspne a  Opio ids c a n re duc e the se nsa tio n o f b re a thle ssne ss b y de c re a sing the ve ntila to r drive  Opio ids na ïve – sta rt 5 to 15 mg a nd titra te to re spo nse  All ro ute s e ffe c tive  Da ta o n ne b ulize d mo rphine is limite d  Co c hra ne re vie w o f da ta fo r pa llia tio n o f b re a thle ssne ss  Mo st studie s lo w q ua lity, sma ll n a nd no t a c o ntro l a rm  No e vide nc e tha t inha le d mo rphine is e ffe c tive  Anxio lytic s a re he lpful, b ut no t a s e ffe c tive a s o pio ids  Additio na l se da tio n a nd po te ntia l to c a use c o nfusio n Dyspne a  Co rtic o ste ro ids ma y tre a t unde rlying dise a se COPD, a sthma  Ma ke pa tie nts fe e l g o o d  Re duc e e de ma o r tumo r g ro wth  Adve rse e ffe c ts, inso mnia  Administe r e a rly in the da y  Bro nc ho dila to rs c a n b e use ful fo r b ro nc ho spa sm  No t muc h da ta in dyspne a 13

  14. 9/29/2016 Na use a a nd vo miting  Co mmo n sympto m in pa tie nts with c a nc e r  F e ma le s  Yo ung e r tha n 65  Sto ma c h o r pa nc re a tic c a nc e r  Re c e nt c he mo the ra py  I mpo rta nt to try a nd fig ure o ut the e tio lo g y fo r se le c tio n o f tre a tme nt  Die ta ry me a sure s a re impo rta nt  Avo id, swe e t, sa lty, fa tty o r spic y fo o ds  Sma ll fre q ue nt me a ls Na use a a nd Vo miting  Do pa mine a nta g o nists, a ntihista mine s, a ntic hlo line rg ic s, se ro to nin a nta g o nists a nd pro kine tic me dic a tio ns a re ma insta y o f tre a tme nt  Pro c hlo rpe ra zine , pro me tha zine a nd c hlo rpro ma zine  Ca n c a use se da tio n, a ntic ho line rg ic a dve rse e ffe c ts b e c a use the y a ffe c t mo re tha n just the do pa mine re c e pto rs  Butyro phe no ne s- spe c ific fo r do pa mine  Pa rkinso ns like sympto ms a s a dve rse e ffe c ts 14

Recommend


More recommend